Montana Compounding Pharmacy Recalls Trimix Injectable Due to Sterility Concerns
Montana Compounding Pharmacy is recalling specific lots of Trimix injectable vials because FDA inspectors observed objectionable conditions that raise concerns about sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls with potential for adverse health consequences (such as sterility issues in injectables) are categorized as Severe (Score 4), particularly when structural or process defects are identified by the agency.
Plain-English summary
Montana Compounding Pharmacy in Missoula, Montana, is recalling 32 vials of Trimix (A;PH,PA) (N) injectable, 2 mL vials. The affected products are prescription-only compounded medications distributed in Montana and North Dakota. The recall involves Lot 02112015:78@15 with an expiry date of 6/1/2015, and Lot 04062015:03@9 with an expiry date of 6/8/2015.
The recall was initiated due to a lack of assurance of sterility. This determination was made after objectionable conditions were observed during a U.S. Food and Drug Administration (FDA) inspection. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Patients who have received this medication should contact their healthcare provider or pharmacist for guidance. Consumers should not use the recalled product and should return it to the pharmacy or follow instructions provided by the recalling firm.
The recalled product
- Product
- Trimix (A;PH,PA) (N), injectable, 160 UG-1.2 mg-9.6/ mg/mL, 2 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT.
- Manufacturer
- Montana Compounding Pharmacy
- Category
- Drug — Compounded Injectable
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot 02112015:78@15
- expiry dates: 6/1/2015
- Lot 04062015:03@9
- expiry dates: 6/8/2015
Distribution
Part of a larger recall action
This product is one of 12 recalled by Montana Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · Montana Compounding Pharmacy
See all →- SevereMontana Compounding Pharmacy Recalls Trimix Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Hyaluronidase Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Glutathione Inhalation Solution Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Glutathione Nasal Solution Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Alprostadil Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29